Manufacturing
Page 1 • 2 itemsGlobal pharma manufacturing insights: Track supply chain, CMC, regulatory compliance, and innovation trends impacting drug production. Stay ahead.
Emergent BioSolutions Partners with Substipharm for $34.5M Japanese Encephalitis Vaccine Manufacturing Deal
Emergent BioSolutions announces $34.5M partnership with Substipharm Biologics to manufacture IMOJEV Japanese encephalitis vaccine for U.S. government distribution.
Bright Path Applauds President's FY2027 Budget for Domestic Pharmaceutical Manufacturing Investment
Bright Path supports President's FY2027 budget proposal investing in advanced pharmaceutical manufacturing technologies to strengthen domestic medicine production capabilities.